For women who are at high risk of developing ovarian breast cancer, prophylactic bilateral oophorectomy to remove the ovaries on both sides and reduce the risk of these cancers may be indicated. The ...
Some people might assume that, when you have your uterus removed via hysterectomy, the surgeon also takes out your ovaries. While that can happen depending on medical necessity, ovary removal goes by ...
July 13, 2006 –- Researchers say that BRCA1- and BRCA2-mutation carriers cut their cancer risk by roughly 80% by undergoing preventive oophorectomy. "We need to be more vigilant about identifying high ...
A study of over 200,500 women who had a hysterectomy for non-cancerous reasons found an increased risk of death in women under 50 years of age when the ovaries and fallopian tubes were also removed ...
Risk-reducing mastectomy and risk-reducing salpingo-oophorectomy are options for the primary prevention of breast and ovarian cancers, and they have been shown in multiple studies to have efficacy.
The removal of both ovaries before menopause was associated with a higher likelihood of chronic health conditions and worse physical function years later, especially for women who underwent the ...
-related breast and ovarian cancers, according to the results of 2 studies published in the May 23 issue of the New England Journal of Medicine. The articles were released early to coincide with ...
Women of childbearing age who had both ovaries removed, in a procedure called bilateral oophorectomy, were more likely to develop heart failure later in life, according to a study being presented at ...
Please provide your email address to receive an email when new articles are posted on . Hysterectomy with bilateral salpingo-oophorectomy dropped risks for breast cancer for younger women and ovarian ...
Temporal and Geographic Variation in the Use of Hematopoietic Growth Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings From a Large Population-Based Cohort Within this cohort, 33 ...
Temporal and Geographic Variation in the Use of Hematopoietic Growth Factors in Older Women Receiving Breast Cancer Chemotherapy: Findings From a Large Population-Based Cohort Within this cohort, 33 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results